Merck Serono and Israel's Kadimastem signed a memorandum of understanding aimed at advancing their stem cell-based drug screening collaboration initiated in 2012, the companies said on Monday.
http://www.reuters.com/article/2013/11/04/kadimastem-merck-idUSL5N0IP0ZW20131104?feedType=RSS&feedName=rbssHealthcareNews
http://www.reuters.com/article/2013/11/04/kadimastem-merck-idUSL5N0IP0ZW20131104?feedType=RSS&feedName=rbssHealthcareNews
No comments:
Post a Comment